ABSTRACT
The Quality-of-Care Network (QCN), launched by WHO and partners, links global and national actors across several countries to improve maternal and newborn health. We examine if QCN facilitated learning, sharing and innovations within and between network countries.
We evaluated the QCN in Bangladesh, Ethiopia, Malawi and Uganda. We conducted a total 227 qualitative interviews with QCN actors iteratively across a 3-year period from October 2019 to March 2022. We also reviewed all accessible QCN documents.
Sharing and learning opportunities were evident through a number of virtual and in-person platforms such as meetings, conferences, webinars, and websites. Conferences and webinars have been hosted on online resource libraries such as the quality-of-care network website. These provided access to materials on strategies and approaches shared by different countries and actors. Innovations were also evident in some countries like Ethiopia. Innovative software applications aimed at boosting the capacity of service providers were developed and these were adopted by countries such as Bangladesh. Locally, there had been strengthening of learning collaborative meetings, coaching and mentorship. Regular meetings such as Stakeholder Coordination Meetings and Learning Collaborative Sessions provided an opportunity for stakeholders to strategize, as well as share and learn approaches within the network.
The network has promoted coordination among stakeholders. Similar approaches to sharing and learning such as Learning Collaborative Sessions were evident across the study countries. Innovations were not as apparent across countries and most of the learning and sharing approaches were similar to those from broader, pre-existing maternal health approaches, adopted from an era preceding the QCN. There was evidence that the introduction of the QCN improved the functionality and visibility of learning and sharing platforms.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work was funded by the Medical Research Council (MRC) Health Systems Research Initiative 5th call via grant MR/S013466/1 to TC at UCL Institute for Global Health, United Kingdom, YS and JS at Johns Hopkins University, United States of America, KA and AK at Diabetic Association of Bangladesh Perinatal Care Project, Bangladesh, CM at Parent and Child Health Initiative, Malawi, GS at Makerere University School of Public Health, Uganda, and ME at University of Oxford, United Kingdom and by the Bill & Melinda Gates foundation via grant INV-007644 to TM at LSHTM, United Kingdom. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Not Applicable
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
University College London Research Ethics Committee (3433/003) phone: +44 20 7679 8717, BADAS Ethical Review Committee (ref: BADAS-ERC/EC/19/00274) phone: +880 5861664150, Ethiopian Public Health Institute Institutional Review Board (ref: EPHI-IRB-240-2020) phone: +251 11 2133499, National Health Sciences Research Committee in Malawi (ref: 19/03/2264) phone: +265 789 400, and Makerere University Institutional Review Board (ref: Protocol 869) phone: +256 414 705500.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Not Applicable
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Not Applicable
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Not Applicable
Data Availability
All data is derived from interviews conducted with stakeholders and document reviews in each country. Careful consideration has been taken to ensure anonymity of the data in the submitted manuscript. Sharing a de-identified data set would jeopardize the conditions of informed consent. Data requests can be made to each of the Ethical Review Committees who approved this research and must be accompanied by a detailed explanation of how the data will be used in line with the ethical approvals received. Contact information for each committee are as follows: University College London Research Ethics Committee (3433/003) phone: +44 20 7679 8717, BADAS Ethical Review Committee (ref: BADAS-ERC/EC/19/00274) phone: +880 5861664150, Ethiopian Public Health Institute Institutional Review Board (ref: EPHI-IRB-240-2020) phone: +251 11 2133499, National Health Sciences Research Committee in Malawi (ref: 19/03/2264) phone: +265 789 400, and Makerere University Institutional Review Board (ref: Protocol 869) phone: +256 414 705500.
